Epigenetic regulator explains why some lung cancer patients become resistant to common therapeutics

Cellular biologists discover why some patients become resistant to standard treatments for nonsmall cell lung cancer.
Read Original Article: Epigenetic regulator explains why some lung cancer patients become resistant to common therapeutics »